BML Capital Management

BML Capital Management as of Dec. 31, 2023

Portfolio Holdings for BML Capital Management

BML Capital Management holds 35 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ishares Tr 0-3 Mnth Treasry (SGOV) 20.6 $27M 270k 100.27
Spdr Ser Tr Bloomberg 1-3 Mo (BIL) 13.9 $18M 200k 91.39
Atea Pharmaceuticals (AVIR) 12.7 $17M 5.5M 3.05
Cyteir Therapeutics 7.5 $9.9M 3.3M 3.04
Tourmaline Bio (TRML) 4.9 $6.4M 246k 26.18
Eliem Therapeutics (ELYM) 4.5 $5.9M 2.2M 2.70
Avrobio Ord (AVRO) 4.2 $5.4M 4.0M 1.36
Theseus Pharmaceuticals 3.4 $4.5M 1.1M 4.05
Athira Pharma (ATHA) 2.7 $3.5M 1.5M 2.43
Adverum Biotechnologies 2.6 $3.4M 4.6M 0.75
Abercrombie & Fitch Cl A (ANF) 2.3 $3.0M 900.00 3370.00
Oramed Pharmaceuticals Com New (ORMP) 2.2 $2.9M 1.3M 2.31
Design Therapeutics (DSGN) 2.1 $2.7M 1.0M 2.65
Connect Biopharma Hldgs Ads (CNTB) 1.9 $2.4M 2.1M 1.18
Reneo Pharmaceuticals (RPHM) 1.6 $2.1M 1.3M 1.60
Astrotech Corp (ASTC) 1.4 $1.9M 220k 8.49
Rain Therapeutics 1.2 $1.6M 1.3M 1.20
Forte Biosciences (FBRX) 1.1 $1.4M 1.8M 0.82
Verrica Pharmaceuticals (VRCA) 1.0 $1.3M 180k 7.32
Wingstop (WING) 0.9 $1.2M 900.00 1345.00
Arca Biopharma (ABIO) 0.9 $1.2M 707k 1.70
Graphite Bio 0.9 $1.1M 445k 2.53
Vistagen Therapeutics Ord (VTGN) 0.6 $771k 150k 5.14
Milestone Pharmaceuticals (MIST) 0.6 $739k 442k 1.67
Lisata Therapeutics (LSTA) 0.6 $737k 270k 2.73
Enliven Therapeutics (ELVN) 0.5 $692k 50k 13.84
Aclaris Therapeutics (ACRS) 0.5 $686k 653k 1.05
Invesco Qqq Tr Unit Ser 1 (QQQ) 0.5 $661k 300.00 2204.00
Neurogene (NGNE) 0.4 $478k 25k 19.38
Homology Medicines 0.3 $455k 748k 0.61
Calcimedica Com New (CALC) 0.3 $416k 145k 2.86
Build-A-Bear Workshop (BBW) 0.3 $401k 1.0k 401.25
Nextcure (NXTC) 0.3 $349k 307k 1.14
Talis Biomedical Corp Com New (TLIS) 0.2 $318k 43k 7.45
Kinnate Biopharma (KNTE) 0.2 $313k 447k 0.70